Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats

Jana Velíšková, Libor Velíšek, Solomon L. Moshe

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: To determine whether seizures have age-specific features, we studied the role of γ-aminobutyric acid(B) (GABA(B)) transmission in rats of various ages (9, 15, 30, and 60 postnatal days). Methods: We used a GABA(B) receptor agonist baclofen (2 or 5 mg/kg intraperitoneally, i.p.) and a GABA(B) receptor antagonist CGP 35348 (100 or 600 mg/kg i.p.) in the pentylenetetrazol (PTZ)-induced model of clonic and tonic-clonic seizures (100 mg/kg subcutaneously, s.c.). Results: Whereas baclofen was anticonvulsant and CGP 35348 proconvulsant in most animals, there were distinct age-related differences in the effectiveness of these drugs and the antagonist had some anticonvulsant activity in adults. Furthermore, the two drugs acting at GABA(B) receptors had a different profile of action in clonic seizures as compared with tonic-clonic seizures. Conclusions: The differences in the age-specific action of the GABA(B) agonist and antagonist suggest that different GABA(B) receptor subsets may mediate the drug effects. The results indicate that putative antiepileptic drugs (AEDs) must be tested during development because it may not be possible to extrapolate age-specific anticonvulsant effects from studies in adult animals.

Original languageEnglish (US)
Pages (from-to)718-722
Number of pages5
JournalEpilepsia
Volume37
Issue number8
StatePublished - 1996

Fingerprint

Pentylenetetrazole
Baclofen
Anticonvulsants
Seizures
GABA-B Receptor Antagonists
GABA-B Receptor Agonists
GABA-B Receptors
Pharmaceutical Preparations
Aminobutyrates
gamma-Aminobutyric Acid
CGP 35348

Keywords

  • Baclofen
  • Newborn
  • Pentylenetetrazol
  • Rats
  • Seizures

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats. / Velíšková, Jana; Velíšek, Libor; Moshe, Solomon L.

In: Epilepsia, Vol. 37, No. 8, 1996, p. 718-722.

Research output: Contribution to journalArticle

Velíšková, Jana ; Velíšek, Libor ; Moshe, Solomon L. / Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats. In: Epilepsia. 1996 ; Vol. 37, No. 8. pp. 718-722.
@article{0d6b5943ac574f77b03ec0faec3ad759,
title = "Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats",
abstract = "Purpose: To determine whether seizures have age-specific features, we studied the role of γ-aminobutyric acid(B) (GABA(B)) transmission in rats of various ages (9, 15, 30, and 60 postnatal days). Methods: We used a GABA(B) receptor agonist baclofen (2 or 5 mg/kg intraperitoneally, i.p.) and a GABA(B) receptor antagonist CGP 35348 (100 or 600 mg/kg i.p.) in the pentylenetetrazol (PTZ)-induced model of clonic and tonic-clonic seizures (100 mg/kg subcutaneously, s.c.). Results: Whereas baclofen was anticonvulsant and CGP 35348 proconvulsant in most animals, there were distinct age-related differences in the effectiveness of these drugs and the antagonist had some anticonvulsant activity in adults. Furthermore, the two drugs acting at GABA(B) receptors had a different profile of action in clonic seizures as compared with tonic-clonic seizures. Conclusions: The differences in the age-specific action of the GABA(B) agonist and antagonist suggest that different GABA(B) receptor subsets may mediate the drug effects. The results indicate that putative antiepileptic drugs (AEDs) must be tested during development because it may not be possible to extrapolate age-specific anticonvulsant effects from studies in adult animals.",
keywords = "Baclofen, Newborn, Pentylenetetrazol, Rats, Seizures",
author = "Jana Vel{\'i}škov{\'a} and Libor Vel{\'i}šek and Moshe, {Solomon L.}",
year = "1996",
language = "English (US)",
volume = "37",
pages = "718--722",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Age-specific effects of baclofen on pentylenetetrazol-induced seizures in developing rats

AU - Velíšková, Jana

AU - Velíšek, Libor

AU - Moshe, Solomon L.

PY - 1996

Y1 - 1996

N2 - Purpose: To determine whether seizures have age-specific features, we studied the role of γ-aminobutyric acid(B) (GABA(B)) transmission in rats of various ages (9, 15, 30, and 60 postnatal days). Methods: We used a GABA(B) receptor agonist baclofen (2 or 5 mg/kg intraperitoneally, i.p.) and a GABA(B) receptor antagonist CGP 35348 (100 or 600 mg/kg i.p.) in the pentylenetetrazol (PTZ)-induced model of clonic and tonic-clonic seizures (100 mg/kg subcutaneously, s.c.). Results: Whereas baclofen was anticonvulsant and CGP 35348 proconvulsant in most animals, there were distinct age-related differences in the effectiveness of these drugs and the antagonist had some anticonvulsant activity in adults. Furthermore, the two drugs acting at GABA(B) receptors had a different profile of action in clonic seizures as compared with tonic-clonic seizures. Conclusions: The differences in the age-specific action of the GABA(B) agonist and antagonist suggest that different GABA(B) receptor subsets may mediate the drug effects. The results indicate that putative antiepileptic drugs (AEDs) must be tested during development because it may not be possible to extrapolate age-specific anticonvulsant effects from studies in adult animals.

AB - Purpose: To determine whether seizures have age-specific features, we studied the role of γ-aminobutyric acid(B) (GABA(B)) transmission in rats of various ages (9, 15, 30, and 60 postnatal days). Methods: We used a GABA(B) receptor agonist baclofen (2 or 5 mg/kg intraperitoneally, i.p.) and a GABA(B) receptor antagonist CGP 35348 (100 or 600 mg/kg i.p.) in the pentylenetetrazol (PTZ)-induced model of clonic and tonic-clonic seizures (100 mg/kg subcutaneously, s.c.). Results: Whereas baclofen was anticonvulsant and CGP 35348 proconvulsant in most animals, there were distinct age-related differences in the effectiveness of these drugs and the antagonist had some anticonvulsant activity in adults. Furthermore, the two drugs acting at GABA(B) receptors had a different profile of action in clonic seizures as compared with tonic-clonic seizures. Conclusions: The differences in the age-specific action of the GABA(B) agonist and antagonist suggest that different GABA(B) receptor subsets may mediate the drug effects. The results indicate that putative antiepileptic drugs (AEDs) must be tested during development because it may not be possible to extrapolate age-specific anticonvulsant effects from studies in adult animals.

KW - Baclofen

KW - Newborn

KW - Pentylenetetrazol

KW - Rats

KW - Seizures

UR - http://www.scopus.com/inward/record.url?scp=0029825909&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029825909&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 718

EP - 722

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 8

ER -